Optimer Pharmaceuticals Inc. - redOrbit

News - Optimer Pharmaceuticals Inc.

Optimer Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference

2012-06-01 02:24:37

SAN DIEGO, June 1, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc.

Analysis of Data from Two Phase 3 Studies Shows DIFICID® Offered Faster Diarrheal Symptom Improvement than Oral Vancomycin in Patients with Cancer Being Treated for Clostridium difficile-Associated Diarrhea (CDAD)

2012-05-16 14:22:41

SAN DIEGO, May 16, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc.

Optimer Pharmaceuticals Reports First Quarter 2012 Financial Results

2012-05-10 10:25:41

SAN DIEGO, May 10, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc.

Optimer Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

2012-05-03 02:31:52

SAN DIEGO, May 3, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc.

Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

2012-05-01 10:25:53

SAN DIEGO, May 1, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc.

More News (159 articles) »